Top 5 Companies that Provide Phage Display Services
Phage display technology is an emerging molecular biology technology. This technology
effectively linked genotype and phenotype, and is one of the most powerful tools in the
post-genome era.
Currently, the phage used to construct the display library is mainly filamentous phagocytosis,
phagocytosis, T4 phagocytosis and T7 phagocytosis. They show that the foreign proteins can
maintain a relatively independent spatial structure and biological activity. With the continuous
improvement and development of this technology, phagocytosis technology has been widely used
in the development of new vaccines, screening of enzyme inhibitors, medical diagnosis and
treatment, peptide drug development, protein interaction research and other fields, and have been
presenting great application prospects.
Because of its great power in various fields, increasing industries are researching on it. Let’s see
the top 5 companies that provide phage display services.
Creative Biolabs
Creative Biolabs develops and commercializes a full range of innovative integrated services that
are based on phage display technology. They have extensive experience in library construction and
screening (such as antibody library screening), antibody humanization, antibody affinity
maturation, production of specific monoclonal antibodies and much more services using phage
display method. They also provide qualified antibody and peptide phage display libraries in-house
to assist customers’ research and project development.
NeoClone
NeoClone is a custom antibody development company, having discovered hundreds of antibodies
for its clients. But there are very difficult targets out there that hybridoma technology alone can’t
solve. Therefore, NeoClone added antibody phage display capabilities to help it develop the
diverse and specific antibody repertoire to difficult targets that you need. Its team now has over 15
years of scFv phage antibody and recombinant antibody experience.
Abzena
Abzena’s phage display technology, using naïve and immune libraries from a variety of species,
including llamas, can be used to identify lead candidates against a vast range of targets, including
GPCR, Ion channels, kinases, growth factors/receptors, TNF superfamily receptors and ligands,
blood proteins, brain neurology targets, tumour biomarkers, cytokines and receptors,
immunoglobulins, ioxins, virus, T cell activators, ligands and receptors, checkpoint modulators
and non protein targets.
ProteoGenix
